Urology Clinical Update: Comparing Newly Approved Therapies for NMIBC

The treatment landscape for non-muscle invasive bladder cancer (NMIBC) continues to evolve as newly approved therapies expand the options available to patients and care teams.

Kinjal (Shah) Patel, PharmD, BCOP (Fox Chase Cancer Center), will review recent approvals, compare the emerging treatment options, and discuss key considerations for understanding their place within the changing NMIBC landscape.

For additional information or login assistance, reach out to NCODA’s Jonathan Rivera.